
HealthTalker appoints Collie Turner
pharmafile | April 22, 2010 | Appointment | Sales and Marketing | Company news, HealthTalker, appointment, new hires, pharm marketing, sales and marketing
Collie Turner has joined US word-of-mouth marketing agency HealthTalker’s leadership team as senior director of strategic partnerships.
She will focus on driving new business and identifying untapped opportunities for HealthTalker’s pharmaceutical-focused campaigns.
With more than 13 years of experience, Turner has provided strategic guidance and account development for the world’s largest pharmaceutical companies including Bristol Myers Squibb, EMD Serono, GlaxoSmithKline, Pfizer, Shire and Wyeth.
“Signing on with HealthTalker is an exciting and challenging prospect for me,” said Turner. “It is this company’s unique offering in the marketplace that will help change the way our clients view the power of consumer influence which ultimately will impact core messaging, product delivery and transparency between drug manufacturers and the general public.”
HealthTalker has grown its base of clients and continues to expand and enhance its scope of services and product offering since its inception in February 2007.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






